A structured interview guide for global impressions: increasing reliability and scoring accuracy for CNS trials

por Targum, Steven D, Houser, Celine, Northcutt, Joanne, Little, Jessica A, Cutler, Andrew J, Walling, David P
Publicado 2013

The Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM and Oral Risperidone: An Open-Label, One-Sequence Study

por Walling, David P, Hassman, Howard A, Anta, Lourdes, Ochoa, Lourdes, Ayani, Ignacio, Martínez, Javier, Gutierro, Ibon
Publicado 2021

Pharmacokinetics and safety of deltoid or gluteal injection of aripiprazole lauroxil NanoCrystal(®) Dispersion used for initiation of the long-acting antipsychotic aripiprazole lau...

por Hard, Marjie L., Wehr, Angela, von Moltke, Lisa, Du, Yangchun, Farwick, Sarah, Walling, David P., Sonnenberg, John
Publicado 2019

Pharmacokinetics, Safety, and Tolerability of a 2-Month Dose Interval Regimen of the Long-Acting Injectable Antipsychotic Aripiprazole Lauroxil: Results From a 44-Week Phase I Stud...

por Weiden, Peter J., Du, Yangchun, von Moltke, Lisa, Wehr, Angela, Hard, Marjie, Marandi, Morteza, Walling, David P.
Publicado 2020

Aripiprazole lauroxil 2-month formulation with 1-day initiation in patients hospitalized for an acute exacerbation of schizophrenia: exploratory efficacy and patient-reported outco...

por Nasrallah, Henry A., Weiden, Peter J., Walling, David P., Du, Yangchun, Yao, Baiyun, Yagoda, Sergey, Claxton, Amy
Publicado 2021

Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia

por Bain, Earle E, Shafner, Laura, Walling, David P, Othman, Ahmed A, Chuang-Stein, Christy, Hinkle, John, Hanina, Adam
Publicado 2017

A long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care...

por Adams, David H, Kinon, Bruce J, Baygani, Simin, Millen, Brian A, Velona, Isabella, Kollack-Walker, Sara, Walling, David P
Publicado 2013

Placebo response mitigation with a participant-focused psychoeducational procedure: a randomized, single-blind, all placebo study in major depressive and psychotic disorders

por Cohen, Elan A., Hassman, Howard H., Ereshefsky, Larry, Walling, David P., Grindell, Vera M., Keefe, Richard S. E., Wyka, Katarzyna, Horan, William P.
Publicado 2020

Usability of a novel digital medicine system in adults with schizophrenia treated with sensor-embedded tablets of aripiprazole

por Peters-Strickland, Timothy, Pestreich, Linda, Hatch, Ainslie, Rohatagi, Shashank, Baker, Ross A, Docherty, John P, Markovtsova, Lada, Raja, Praveen, Weiden, Peter J, Walling, David P
Publicado 2016

Evaluation of the Efficacy, Safety, and Tolerability of BI 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia: A Randomized, Double-Blind, Plac...

por Brown, David, Nakagome, Kazuyuki, Cordes, Joachim, Brenner, Ronald, Gründer, Gerhard, Keefe, Richard S E, Riesenberg, Robert, Walling, David P, Daniels, Kristen, Wang, Lara, McGinniss, Jennifer, Sand, Michael
Publicado 2019

A Randomized, Double-Blind, Multicenter, Noninferiority Study Comparing Paliperidone Palmitate 6-Month Versus the 3-Month Long-Acting Injectable in Patients With Schizophrenia

por Najarian, Dean, Sanga, Panna, Wang, Steven, Lim, Pilar, Singh, Arun, Robertson, Mary Jane, Cohen, Kristin, Schotte, Alain, Milz, Ruth, Venkatasubramanian, Raja, T’Jollyn, Huybrecht, Walling, David P, Galderisi, Silvana, Gopal, Srihari
Publicado 2021

Proof-of-Mechanism Study of the Phosphodiesterase 10 Inhibitor RG7203 in Patients With Schizophrenia and Negative Symptoms

por Umbricht, Daniel, Abt, Markus, Tamburri, Paul, Chatham, Christopher, Holiga, Štefan, Frank, Michael J., Collins, Anne G.E., Walling, David P., Mofsen, Rick, Gruener, Daniel, Gertsik, Lev, Sevigny, Jeff, Keswani, Sanjay, Dukart, Juergen
Publicado 2021